Recent in vitro and in vivo studies have suggested that aspirin may suppress cancer cell growth and induce apoptosis through activation of protein kinase A (PRKA, also referred to as AMPK), inhibition of MTOR downstream signaling, and inhibition of PI3K-induced prostaglandin E2 synthesis [46–48]. Here, MTOR is linked to cancer.